StockData

Positron Corp (POSC) stock

POSCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.70+0.15 (+9.68%)

Close on Oct 19, 2026Market cap $55.84MP/E –Yield –

Positron r&d expenses

Research and development expenses are spending on new products and technology.

Positron's R&D Expenses for the twelve months ending Sep 30, 2015 was $250.00K, down 43.7% year over year. For fiscal 2014 it was $471.00K, down 16.5% from the year before. The highest annual figure on record is $1.32M in fiscal 2011.

Annual r&d expenses

PeriodPeriod endValueChange
FY2014Dec 31, 2014$471.00K-16.5%
FY2013Dec 31, 2013$564.00K-40.0%
FY2012Dec 31, 2012$940.00K-28.5%
FY2011Dec 31, 2011$1.32M+3.1%
FY2010Dec 31, 2010$1.28M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2015Sep 30, 2015$2.00K-98.4%
Q2 FY2015Jun 30, 2015$5.00K-95.8%
Q1 FY2015Mar 31, 2015$120.00K+17.6%
Q4 FY2014Dec 31, 2014$123.00K+28.1%
Q3 FY2014Sep 30, 2014$126.00K-5.3%
Q2 FY2014Jun 30, 2014$120.00K+12.1%
Q1 FY2014Mar 31, 2014$102.00K-55.3%
Q4 FY2013Dec 31, 2013$96.00K-48.1%
Q3 FY2013Sep 30, 2013$133.00K-28.5%
Q2 FY2013Jun 30, 2013$107.00K-58.2%
Q1 FY2013Mar 31, 2013$228.00K-27.2%
Q4 FY2012Dec 31, 2012$185.00K-26.9%
Q3 FY2012Sep 30, 2012$186.00K-53.6%
Q2 FY2012Jun 30, 2012$256.00K-21.7%
Q1 FY2012Mar 31, 2012$313.00K-6.3%
Q4 FY2011Dec 31, 2011$253.00K-35.9%
Q3 FY2011Sep 30, 2011$401.00K-3.8%
Q2 FY2011Jun 30, 2011$327.00K+97.0%
Q1 FY2011Mar 31, 2011$334.00K–
Q4 FY2010Dec 31, 2010$395.00K–
Q3 FY2010Sep 30, 2010$417.00K–
Q2 FY2010Jun 30, 2010$166.00K–

More Positron figures

See a number that looks wrong?